Search research articles
Contact Us
Filters
Showing results (51-60 of 58) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 58 results.
Cancer
|
September 15, 1991
Intensive chemotherapy induction followed by interferon-alpha maintenance in patients with Philadelphia chromosome-positive chronic myelogenous leukemia
H M Kantarjian, M Talpaz, M J Keating, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1992
Treatment of chronic myelogenous leukemia in accelerated and blastic phases with daunorubicin, high-dose cytarabine, and granulocyte-macrophage colony-stimulating factor
H M Kantarjian, M Talpaz, D Kontoyiannis, et al.
Cancer
|
April 15, 1980
Factors related to length of complete remission in adult acute leukemia
M J Keating, T L Smith, E A Gehan, et al.
The American Journal of Medicine
|
November 1, 1988
Significance and correlations of molecular analysis results in patients with Philadelphia chromosome-negative chronic myelogenous leukemia and chronic myelomonocytic leukemia
H M Kantarjian, M Shtalrid, R Kurzrock, et al.
Virology
|
September 1, 1984
Antibodies to chromosome 21 coded cell surface components block binding of human alpha interferon but not gamma interferon to human cells
L M Shulman, M E Kamarck, D L Slate, et al.
Cancer Research
|
August 1, 1974
Prognostic correlations and response to treatment in advanced metastatic malignant melanoma
L H Einhorn, M A Burgess, C Vallejos, et al.
Cancer
|
October 1, 1976
Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma
E M McKelvey, J A Gottlieb, H E Wilson, et al.
Cancer
|
October 15, 1982
The natural history of resectable metastatic melanoma (Stage IVA melanoma)
L G Feun, J Gutterman, M A Burgess, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 58) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 58 results.
Cancer
|
September 15, 1991
Intensive chemotherapy induction followed by interferon-alpha maintenance in patients with Philadelphia chromosome-positive chronic myelogenous leukemia
H M Kantarjian, M Talpaz, M J Keating, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1992
Treatment of chronic myelogenous leukemia in accelerated and blastic phases with daunorubicin, high-dose cytarabine, and granulocyte-macrophage colony-stimulating factor
H M Kantarjian, M Talpaz, D Kontoyiannis, et al.
Cancer
|
April 15, 1980
Factors related to length of complete remission in adult acute leukemia
M J Keating, T L Smith, E A Gehan, et al.
The American Journal of Medicine
|
November 1, 1988
Significance and correlations of molecular analysis results in patients with Philadelphia chromosome-negative chronic myelogenous leukemia and chronic myelomonocytic leukemia
H M Kantarjian, M Shtalrid, R Kurzrock, et al.
Virology
|
September 1, 1984
Antibodies to chromosome 21 coded cell surface components block binding of human alpha interferon but not gamma interferon to human cells
L M Shulman, M E Kamarck, D L Slate, et al.
Cancer Research
|
August 1, 1974
Prognostic correlations and response to treatment in advanced metastatic malignant melanoma
L H Einhorn, M A Burgess, C Vallejos, et al.
Cancer
|
October 1, 1976
Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma
E M McKelvey, J A Gottlieb, H E Wilson, et al.
Cancer
|
October 15, 1982
The natural history of resectable metastatic melanoma (Stage IVA melanoma)
L G Feun, J Gutterman, M A Burgess, et al.
Page
of 6